| __timestamp | Lantheus Holdings, Inc. | Rhythm Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 72429000 | 1213000 |
| Thursday, January 1, 2015 | 78634000 | 3425000 |
| Friday, January 1, 2016 | 75374000 | 6311000 |
| Sunday, January 1, 2017 | 92157000 | 9518000 |
| Monday, January 1, 2018 | 93326000 | 28080000 |
| Tuesday, January 1, 2019 | 103132000 | 36550000 |
| Wednesday, January 1, 2020 | 110171000 | 46125000 |
| Friday, January 1, 2021 | 218817000 | 68486000 |
| Saturday, January 1, 2022 | 233827000 | 92032000 |
| Sunday, January 1, 2023 | 267194000 | 117532000 |
Unleashing the power of data
In the competitive landscape of the pharmaceutical industry, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Lantheus Holdings, Inc. and Rhythm Pharmaceuticals, Inc. offer a fascinating study in contrasts over the past decade. From 2014 to 2023, Lantheus Holdings has seen a steady increase in SG&A expenses, peaking at approximately 267 million in 2023, a growth of over 270% from 2014. In contrast, Rhythm Pharmaceuticals started with minimal SG&A costs, around 1.2 million in 2014, but experienced a dramatic rise to about 118 million by 2023, marking an exponential increase.
While both companies have expanded their SG&A budgets, Lantheus Holdings' expenses have grown at a more measured pace compared to Rhythm Pharmaceuticals' rapid escalation. This data suggests that Lantheus Holdings may have a more strategic approach to managing these costs, potentially leading to better long-term financial health.
Gilead Sciences, Inc. vs Rhythm Pharmaceuticals, Inc.: SG&A Expense Trends
Biogen Inc. and Rhythm Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: United Therapeutics Corporation vs Rhythm Pharmaceuticals, Inc.
Dr. Reddy's Laboratories Limited or Rhythm Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Ascendis Pharma A/S and Lantheus Holdings, Inc.: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Halozyme Therapeutics, Inc. vs Lantheus Holdings, Inc. Trends and Insights
Selling, General, and Administrative Costs: Lantheus Holdings, Inc. vs ImmunityBio, Inc.
Operational Costs Compared: SG&A Analysis of Lantheus Holdings, Inc. and Ligand Pharmaceuticals Incorporated
Lantheus Holdings, Inc. and Novavax, Inc.: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Cytokinetics, Incorporated vs Rhythm Pharmaceuticals, Inc. Trends and Insights
Cost Management Insights: SG&A Expenses for ADMA Biologics, Inc. and Rhythm Pharmaceuticals, Inc.
Rhythm Pharmaceuticals, Inc. and Viridian Therapeutics, Inc.: SG&A Spending Patterns Compared